Most of us follow a professional sporting team. Each year we start the season with hope and enthusiasm that ‘this year’ will be ‘our year’. Have our recruiters and management assembled the right mix of youth and experience and will they be coached to their strengths? Is the framework in place to raise our odds of success ?
Australian biotech company VivaZome Therapeutics has announced that it has been awarded an Australian Government CRC-P grant of $2.18m in support of the project “Enabling Exosome Therapy: Developing an Advanced Manufacturing Process”, with the funds provided under the Advanced Manufacturing Scheme.
INFOGRAPHIC: A snapshot of how SeerPharma has supported its clients in 2017 on matters of QA and GMP compliance.
There are many phases in a computerised system project and all are important, but none more so than gathering User Requirements.
The launch of new temperature sensitive biologics, increasing regulations, growing cost- pressures are putting more complex demands on the biopharma industry’s high-stakes logistics environment.
The biologics manufacturing industry has undergone several changes over the past few years starting from the development of better expression systems to modular and flexible manufacturing facilities including the emergence and use of disposables. However, there is a need for higher productivity with upstream process development and cost-effective...
The TGA has published details of the 12 month graduated transition period to PIC/S Guide to GMP PE 009-13, commencing 01 January 2018. The key changes and a transition plan have been summarised in tables by chapter and appendix and are linked here for your convenience.
SeerPharma reached a milestone this quarter with the 10,000th trainee going through our cloud-based online GMP training, "E-learning".
A multinational pharmaceutical company required assistance to Validate equipment used in the manufacturing of an Active Pharmaceutical Ingredient (API). The facility was recently refitted to handle the manufacturing of a new API for global supply.
A global provider of medical device implants approached SeerPharma to conduct an internal ISO 13485 audit of their operations.
Copyright © SeerPharma
